Product NDC: | 61748-201 |
Proprietary Name: | Clindamycin phosphate |
Non Proprietary Name: | Clindamycin phosphate |
Active Ingredient(s): | 10 mg/mL & nbsp; Clindamycin phosphate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 61748-201 |
Labeler Name: | VersaPharm Incorporated |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065513 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100710 |
Package NDC: | 61748-201-60 |
Package Description: | 1 JAR in 1 CARTON (61748-201-60) > 60 APPLICATOR in 1 JAR > 1 mL in 1 APPLICATOR |
NDC Code | 61748-201-60 |
Proprietary Name | Clindamycin phosphate |
Package Description | 1 JAR in 1 CARTON (61748-201-60) > 60 APPLICATOR in 1 JAR > 1 mL in 1 APPLICATOR |
Product NDC | 61748-201 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Clindamycin phosphate |
Dosage Form Name | SOLUTION |
Route Name | TOPICAL |
Start Marketing Date | 20100710 |
Marketing Category Name | ANDA |
Labeler Name | VersaPharm Incorporated |
Substance Name | CLINDAMYCIN PHOSPHATE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |